IRS2 and breast cancer: Both receptors activate insulin receptor substrate proteins (IRS-1 and IRS-2), which act as scaffolds for other signaling pathways, such as PI3K/AKT/mTOR and Ras/Raf/MAPK, crucial for BC subtypes [13,14].